ArticleFrontiers in medicine2026
Reliability-aware fusion of ocular thermal imaging and radiometric features for proof-of-concept classification of diabetic retinopathy vs. healthy controls.
Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Early detection of diabetic retinopathy (DR) is crucial for preventing permanent vision impairment, yet widely used screening techniques such as fundus photography and optical coherence tomography (OCT) depend on expensive equipment and expert clinical interpretation, restricting their use in large-scale and low-resource environments. To overcome these challenges, this study introduces ReliaFusion-Net, a reliability-aware multimodal framework for proof-of-concept binary classification of eyes with DR vs. healthy controls, using thermal eye images and radiometric temperature features. Methods: The proposed ReliaFusion-Net architecture combines bidirectional co-attention with feature-wise linear modulation to effectively model complementary relationships between thermal image features and physiological temperature descriptors. A clinically curated dataset containing 558 thermal eye images, including 278 normal and 280 diabetic samples, was collected with ophthalmologist support. The framework was trained and evaluated for binary classification, and cross-validation experiments were conducted to assess model generalization. Results: Using an EdgeNeXt backbone, the proposed model achieved 93.18% accuracy, 93.26% F1-score, and 0.9785 AUC on the test set. Cross-validation results further confirmed strong generalization performance. These findings indicate that the reliability-aware multimodal fusion strategy effectively discriminates eyes with DR from healthy controls using non-invasive thermal imaging data. Discussion: By dynamically adapting modality contributions based on reliability, ReliaFusion-Net overcomes limitations associated with traditional fixed fusion strategies and improves classification robustness. Overall, the findings demonstrate proof-of-concept of reliability-aware multimodal learning to distinguish eyes with DR from healthy controls using non-invasive thermal imaging, with potential applicability in tele-ophthalmology settings. Future work focuses on multi-stage disease classification and longitudinal disease progression analysis.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.